Detalles de la búsqueda
1.
Binding Studies of TNF Receptor Superfamily (TNFRSF) Receptors on Intact Cells.
J Biol Chem
; 291(10): 5022-37, 2016 Mar 04.
Artículo
Inglés
| MEDLINE | ID: mdl-26721880
2.
Targeting of the WT191-138 fragment to human dendritic cells improves leukemia-specific T-cell responses providing an alternative approach to WT1-based vaccination.
Cancer Immunol Immunother
; 66(3): 319-332, 2017 Mar.
Artículo
Inglés
| MEDLINE | ID: mdl-27896368
3.
Correction: Binding studies of TNF receptor superfamily (TNFRSF) receptors on intact cells.
J Biol Chem
; 295(32): 11377, 2020 Aug 07.
Artículo
Inglés
| MEDLINE | ID: mdl-32769175
4.
TWEAK inhibits TRAF2-mediated CD40 signaling by destabilization of CD40 signaling complexes.
J Immunol
; 191(5): 2308-18, 2013 Sep 01.
Artículo
Inglés
| MEDLINE | ID: mdl-23918987
5.
Fibroblast growth factor inducible (Fn14)-specific antibodies concomitantly display signaling pathway-specific agonistic and antagonistic activity.
J Biol Chem
; 288(19): 13455-66, 2013 May 10.
Artículo
Inglés
| MEDLINE | ID: mdl-23532848
6.
Generic design principles for antibody-based tumour necrosis factor (TNF) receptor 2 (TNFR2) agonists with FcγR-independent agonism.
Theranostics
; 14(2): 496-509, 2024.
Artículo
Inglés
| MEDLINE | ID: mdl-38169605
7.
Studies of binding of tumor necrosis factor (TNF)-like weak inducer of apoptosis (TWEAK) to fibroblast growth factor inducible 14 (Fn14).
J Biol Chem
; 287(1): 484-495, 2012 Jan 02.
Artículo
Inglés
| MEDLINE | ID: mdl-22081603
8.
CD40- and CD95-specific antibody single chain-Baff fusion proteins display BaffR-, TACI- and BCMA-restricted agonism.
MAbs
; 12(1): 1807721, 2020.
Artículo
Inglés
| MEDLINE | ID: mdl-32840410
9.
TNFRSF receptor-specific antibody fusion proteins with targeting controlled FcγR-independent agonistic activity.
Cell Death Dis
; 10(3): 224, 2019 03 04.
Artículo
Inglés
| MEDLINE | ID: mdl-30833543
Resultados
1 -
9
de 9
1
Próxima >
>>